pre-IPO PHARMA
COMPANIES VC JOBS NEWS CONTACT

TAG: Stem Cell

Sep 18, 2023

Therapeutic Solutions International Recruits Internationally Renowned Stem Cell Clinician and San Diego Top Doctor to Scientific Advisory Board

Sep 11, 2023

Therapeutic Solutions International Reports Landmark Advancement in Stem Cell Therapy of Frontotemporal Dementia

Sep 5, 2023

Heartseed Enters into induced Pluripotent Stem Cell Purification Patent License Agreement for Commercialization of Cell Therapy

May 25, 2023

Heartseed raises 2 billion JPY in series D funding to accelerate development of iPSC-derived stem cell therapy for heart failure

May 22, 2023

Therapeutic Solutions International Spin-Off Res Nova Bio Leverages FDA Cleared Tumor Blood Vessel Targeting Technology to Intravenously Deliver Cancer Killing Viruses

Apr 20, 2023

Therapeutic Solutions International Files to Initiate Phase III Clinical Trial for Acute Respiratory Distress Syndrome (ARDS) Leveraging Positive COVID-19 Data with JadiCell Stem Cell Therapy

Apr 3, 2023

Therapeutic Solutions International Spin Off Campbell Neurosciences Announces Novel Mechanistic Data on CampbellCell Stem Cell Therapy for Schizophrenia

Mar 13, 2023

Therapeutic Solutions International Advances Chronic Obstructive Pulmonary Disease Program by Identifying Novel B Regulatory Cell Mechanism of Action for JadiCell Universal Donor Adult Stem Cell

Feb 21, 2023

Therapeutic Solutions International Launches Veltmeyer Institute for Advanced Biologics

Jan 9, 2023

Therapeutic Solutions International Identifies Novel Cellular Marker Associated with Therapeutic Response to JadiCell Stem Cell Treatment

Dec 12, 2022

Orca Bio Presents Encouraging Interim Clinical Data on Orca-Q in Haploidentical Allogeneic Hematopoietic Stem Cell Transplants at 64th ASH Annual Meeting

Dec 5, 2022

Therapeutic Solutions International Announces Improvements in Autism, Amyotrophic Lateral Sclerosis and Schizophrenia Cases Treated by Veltmeyer Institute for Advanced Therapeutics

Nov 28, 2022

Therapeutic Solutions International Granted Broad Patent on Treatment of Neurodegenerative Conditions

Nov 18, 2022

EdiGene Announces Completion of Last Patient Dosing in Phase I Clinical Trial of ET-01, its Investigational Gene-editing Hematopoietic Stem Cell Therapy for Transfusion Dependent β-thalassemia

Nov 10, 2022

Umoja Biopharma Presents New Preclinical Data on its Integrated In Vivo CAR T and Engineered Induced Pluripotent Stem Cell Platform Technologies at the Society for Immunotherapy of Cancer (SITC) 37th Annual Meeting

Nov 9, 2022

Therapeutic Solutions International Launches Spin-Off Breathe Biologics Aimed at Curing Chronic Obstructive Pulmonary Disease (COPD)

Nov 3, 2022

EdiGene to Present Preliminary Safety and Efficacy Results of an Investigator Initiated Trial for ET-01, its Investigational Gene Editing Hematopoietic Stem Cell Therapy, at the 64th American Society of Hematology (ASH) Annual Meeting and Exposition

Oct 24, 2022

Therapeutic Solutions International Announces Successful Treatment of Epilepsy in Animal Model and Complete Cessation of Seizures in Treatment Resistant Patient

Oct 6, 2022

Aruna Bio Announces Presentation on Neural Exosome Treatment Opportunities and Lead Program, AB126 at Exosome Based Therapeutic Development Summit

Oct 3, 2022

Therapeutic Solutions International Identifies CD103 Expressing Dendritic Cells and Exosomes Thereof as Novel Mechanism for JadiCell Mesenchymal Stem Cell Mediated Lung Protection

Sep 20, 2022

Therapeutic Solutions International Secures Financing to Complete Current Phase III Stem Cell Clinical Trial

Sep 19, 2022

Therapeutic Solutions International Spin-Off Company Campbell Neurosciences Announces Successful Preclinical Studies of CampbellCell for Treatment of Bipolar Disorder

Aug 25, 2022

Therapeutic Solutions International Files with FDA to Expand ongoing Phase III Clinical Trial to Include All Causes of Acute Respiratory Distress Syndrome

Aug 23, 2022

ElevateBio Partners with the California Institute for Regenerative Medicine to Accelerate the Development of Regenerative Medicines

Aug 12, 2022

Therapeutic Solutions International Reports Superior Efficacy of ApoptoCyte™ on Chronic Obstructive Pulmonary Disease Model Compared to Conventional Stem Cell Approaches

Aug 4, 2022

ElevateBio Announces the Formation of a New Company With George Daley, M.D., Ph.D., and Boston Children’s Hospital to Develop iPSC-Derived Allogeneic Immune Therapies

Aug 2, 2022

Orca Bio Announces the Precision-T Phase 3 Study is Open and Enrolling Patients at Transplant Centers Across the U.S.

Jul 18, 2022

Therapeutic Solutions International Granted Emergency IND by FDA for Expanded Patient Access to JadiCell™ Universal Donor Stem Cell for COVID-19 ARDS Outside of Ongoing Phase III Clinical Trial

Jul 14, 2022

Global Stem Cell Partnering Terms and Agreements 2010-2022: Featuring Celltex Therapeutics, Promega, Transgenomic and More

Jul 11, 2022

Vertex to Acquire ViaCyte, With the Goal of Accelerating its Potentially Curative VX-880 Programs in Type 1 Diabetes

Jun 16, 2022

Umoja Biopharma Presents Data on its Engineered Induced Pluripotent Stem Cell Platform at the 2022 International Society for Stem Cell Research Annual Meeting

May 25, 2022

Therapeutic Solutions International Recruits Dr. Donald Banerji to Scientific Advisory Board

May 23, 2022

Therapeutic Solutions International Receives IND Number 28508 for Chronic Obstructive Pulmonary Disease Clinical Trial and Enters Binding Discussions with FDA for Initiation of Phase I/II Clinical Trial

May 9, 2022

Therapeutic Solutions International Files Investigational New Drug Application for Treatment of Chronic Obstructive Pulmonary Disease (COPD) Using JadiCell™ Universal Donor Adult Stem Cells

May 2, 2022

Therapeutic Solutions International Announces Launching of Phase III Clinical Trial for Treating COVID-19 Lung Damage Using its JadiCell™ Universal Donor Stem Cell Drug

Apr 21, 2022

Boehringer Ingelheim launches RenuTend™: a new stem cell therapy to improve the healing of tendon and suspensory ligament injuries in horses

Apr 19, 2022

Therapeutic Solutions International Identifies Novel Biological Pathway Utilized by its Phase III Adult Stem Cell Product JadiCell™ to Stimulate Healing of Injured Lung Tissue

Apr 6, 2022

Notch Therapeutics Welcomes Deepika Rajesh as VP, Stem Cell Biology and Developmental Immunology

Apr 4, 2022

Neurona Therapeutics to Present at the Locust Walk Stem Cell Tx Conference

Mar 28, 2022

Therapeutic Solutions International Selects Premier Regenerative Medicine CRO Biorasi to Initiate and Run Phase III FDA Registration Clinical Trial for JadiCell™ Universal Donor Adult Stem Cell Product

Mar 25, 2022

Therapeutic Solutions International Completes Purchase of FDA Phase III JadiCell Stem Cell Investigational New Drug Application from University of Miami

Mar 7, 2022

Therapeutic Solutions International Announces ApoptoCyte Procedure for Enhancing Stem Cell Activity

Mar 2, 2022

Propanc Biopharma’s Cancer Stem Cell Technology Offers Renewed Hope to Achieve a Total Victory Against Metastatic Cancer

Feb 15, 2022

Trestle Biotherapeutics Announces License Agreement with Kumamoto University for Key Stem Cell Biology Technology for Regenerative Medicine

Feb 8, 2022

Morphocell Technologies Announces a New Stem Cell Process That May Pave Way for Liver Cell Therapy and Drug Development

Feb 8, 2022

Trestle Biotherapeutics Licenses Innovations from Harvard University to Develop 3D Biofabricated Tissues to Treat Kidney Failure

Jan 24, 2022

EdiGene Enters Strategic RandD Collaboration with Haihe Laboratory of Cell Ecosystem to Develop Hematopoietic Stem Cell Regenerative Therapies and Platform Technologies

Jan 6, 2022

Notch Therapeutics' Peter Zandstra Appointed to the Order of Canada

Dec 30, 2021

Therapeutic Solutions International Successfully Treats “No Option” Patients with its JadiCell™ Stem Cell Therapy While Advancing Preparations for Phase III COVID-19 Clinical Trial

Nov 4, 2021

EdiGene to Present Latest Research on A Novel Surface Marker and Migration of Hematopoietic Stem Cell (HSC) That Could Enhance HSC Gene Therapy and HSC Transplantation at the 63rd American Society of Hematology (ASH) Annual Meeting and Exposition

Sep 24, 2021

Jasper Therapeutics Closes Transaction With Amplitude Healthcare Acquisition Corporation, Creating a Publicly Traded Biotechnology Company Dedicated to Enabling Cures Through Hematopoietic Stem Cell Therapy

Sep 13, 2021

ViaCyte Appoints Stem Cell Therapy Expert Dr. Timothy Kieffer as Chief Scientific Officer

Sep 8, 2021

EdiGene Announces Clinical Sites Activation and First Patient Enrolled in Multicenter Phase I Clinical Trial of its Investigational Gene-editing Hematopoietic Stem Cell Therapy ET-01 for Patients with Transfusion Dependent β-thalassemia

Aug 17, 2021

ERS Genomics and Cellular Engineering Technologies Enter CRISPR/Cas9 License Agreement

Aug 11, 2021

IN8bio Completes Dosing of First Cohort in Phase 1 Clinical Trial with Allogeneic Gamma Delta T-Cell Therapy in Leukemia Patients Undergoing Hematopoietic Stem Cell Transplant

Aug 3, 2021

Tachyon and AbCellera Collaborate to Develop Novel Antibody Therapeutic Targeting TGF-β Superfamily Member for the Treatment of Cancer

Jul 9, 2021

PureTech Founded Entity Vor Biopharma Announces Collaboration with Janssen to Develop Engineered Hematopoietic Stem Cell Transplants Combined with a Bi-Specific Antibody Therapy for Acute Myeloid Leukemia (AML)

Jul 8, 2021

Vor Biopharma Announces Collaboration with Janssen to Develop Engineered Hematopoietic Stem Cell Transplants Combined With a Bi-Specific Antibody Therapy for Acute Myeloid Leukemia (AML)

Jun 29, 2021

Celularity Announces Expansion of Human Placental Hematopoietic Stem Cell Derived Natural Killer Cells (CYNK-001) Phase 1 Trial in Patients with Acute Myeloid Leukemia

Jun 14, 2021

Jasper Therapeutics Announces Orphan Drug and Rare Pediatric Disease Designations for JSP191 for Conditioning Treatment Prior to Stem Cell Transplant

Jun 11, 2021

Heartseed Raises $37 Million in Series C Funding to Accelerate Development of iPSC-derived Stem Cell Therapy for Heart Failure

May 19, 2021

Jasper Therapeutics Announces Updated 90-day Data from Phase 1 Clinical Trial of JSP191 as Targeted Stem Cell Conditioning Agent in Older Patients with Myelodysplastic Syndromes or Acute Myeloid Leukemia Undergoing Hematopoietic Cell Transplantation

May 6, 2021

Jasper Therapeutics and Amplitude Healthcare Acquisition Corporation Announce Merger to Create a Publicly Listed Leading Biotechnology Company in Hematopoietic Stem Cell Transplantation

Apr 6, 2021

MitoImmune Received FDA Clearance of IND Application for MIT-001, a Novel Anti-Inflammatory/Anti-Necrotic Therapy for Oral Mucositis in CCRT patients with Head and Neck Cancer

Mar 18, 2021

ElevateBio Announces Chief Scientific Officer of Regenerative Medicine, Melissa Carpenter, PhD, Elected to the International Society for Stem Cell Research Board of Directors

Feb 22, 2021

Hope Biosciences Stem Cell Research Foundation Secures Authorization for “Long Haulers” COVID Study

Feb 22, 2021

Company Profile for Hope Biosciences Stem Cell Research Foundation

Feb 11, 2021

Ensoma Launches to Pioneer Next-Generation In Vivo Approach to Deliver First “Off-the-shelf” Genomic Medicines

Feb 8, 2021

Jasper Therapeutics Announces Positive Data from Phase 1 Clinical Trial of JSP191 as Targeted Stem Cell Conditioning Agent in Patients with Myelodysplastic Syndromes or Acute Myeloid Leukemia Undergoing Hematopoietic Cell Transplantation

Jan 18, 2021

EdiGene Announces Approval of its IND Application for its CRISPR/Cas 9 Gene-editing Hematopoietic Stem Cell Therapy ET-01 in β-thalassemia by China National Medical Products Administration

Dec 8, 2020

Global Stem Cell Therapy Market (2020 to 2025) - Players Include Biotime, Sanbio and Bluerock Therapeutics - ResearchAndMarkets.com

Dec 7, 2020

Jasper Therapeutics Announces Data from First Transplant-naive Patient in Phase 1 Clinical Trial of JSP191 as Conditioning Agent in Patients with SCID Undergoing Hematopoietic Cell Transplantation

Dec 6, 2020

ElevateBio’s HighPassBio Presents on Novel T Cell Receptor Cell Therapy for Leukemia Relapse at 62nd Annual ASH Meeting

Nov 11, 2020

Angiocrine Bioscience Announces FDA Regenerative Medicine Advanced Therapy (RMAT) Designation Granted to AB-205 (Universal E-CEL Cell Therapy) to Treat Organ Vascular Niche Injuries for the Prevention of Severe Toxicities in Lymphoma Patients undergoing Curative High-Dose Therapy with Autologous Stem Cell Transplantation

Oct 30, 2020

Sana Biotechnology Announces Acquisition of Oscine

Oct 27, 2020

NexImmune Establishes Research Initiative with City of Hope to Focus on Novel Immunotherapeutic Approaches to Acute Myeloid Leukemia

Oct 26, 2020

EdiGene Announces IND Application for its CRISPR/Cas 9 Gene-editing Hematopoietic Stem Cell Therapy ET-01 in β-thalassemia Accepted for Review by China National Medical Products Administration

Oct 9, 2020

AIVITA Biomedical's Stem Cell Therapeutic in Vision Loss Published in Investigative Ophthalmology and Vision Science

Sep 29, 2020

Cytovia Therapeutics to present at Jefferies Cell Therapy Virtual Summit, BIO Investor Forum and New York Stem Cell Foundation Conference in October 2020

Sep 22, 2020

Jasper Therapeutics Doses First Patient in Phase 1 Clinical Trial of JSP191 as Conditioning Agent for Patients with Myelodysplastic Syndromes/Acute Myeloid Leukemia Undergoing Hematopoietic Cell Transplantation

Jul 27, 2020

Boehringer Ingelheim acquires GST to strengthen its stem cell capabilities in Animal Health

Jun 17, 2020

Verve Therapeutics CEO Sekar Kathiresan, M.D., to Give Keynote Presentation at the International Society for Stem Cell Research (ISSCR) 2020 Virtual Annual Meeting

Jun 11, 2020

Partner Therapeutics Announces Initiation of Clinical Trial Evaluating Leukine in T Cell Replete HLA-mismatched Haploidentical Stem Cell Transplant

Jun 1, 2020

Longeveron Announces Japanese Approval of Clinical Trial for Treatment of Aging Frailty With Longeveron's Stem Cells

May 26, 2020

ViaCyte Announces $27 Million Financing to Advance Next Generation Cell Therapies for Diabetes

May 23, 2020

Hope Biosciences Stem Cell Research Foundation Completes First Treatments for COVID-19

May 12, 2020

Incysus Therapeutics Treats First Patient in Phase 1 Study of Gamma Delta (γδ) T Cell Immunotherapy in Leukemia and Lymphoma Patients Undergoing Allogeneic Stem Cell Transplantation

May 6, 2020

Hope Biosciences Receives FDA Approval to Commence First Stem Cell Clinical Trial for Protection Against COVID-19

Mar 31, 2020

Notice Regarding Business Alliance Between Sanbio and Ocumension in the Research, Development and Commercialization of Innovative Stem Cell Therapies for Ophthalmic Diseases

Feb 20, 2020

Breath Therapeutics, a Zambon company, initiates BOSTON-3 and BOSTON-4, two additional clinical studies for the treatment of bronchiolitis obliterans syndrome (BOS)

Jan 9, 2020

CYTOVIA Therapeutics and the New York Stem Cell Foundation Research Institute enter into a partnership to develop iPSC derived CAR NK Therapeutics

Dec 12, 2019

Aspen Neuroscience Launches With $6.5 Million Seed Funding to Advance First-of-its-Kind Personalized Cell Therapy for Parkinson's Disease

Dec 6, 2019

Jasper Therapeutics Launches with $35 Million Series A Financing to Develop and Commercialize Innovative Conditioning Agents and Therapies to Transform Curative Hematopoietic Cell Transplants

Nov 20, 2019

Hope Biosciences Receives FDA Approval to Commence Groundbreaking Stem Cell Clinical Trial for Alzheimer’s Disease

Nov 11, 2019

Promethera Biosciences Presents Updated Clinical Results at AASLD 2019 for World’s First Stem Cell Therapy Trial using HepaStem™ in Acute-on-Chronic Liver Failure

Nov 4, 2019

ViaCyte to Present at ISSCR International Symposium: Stem Cell Biology to New Therapies

Oct 16, 2019

Hope Biosciences Opens First Phase I/II Stem Cell Trial for Brain Injury Treatment

Oct 1, 2019

ElevateBio Launches HighPassBio to Advance Novel Targeted T Cell Immunotherapies with Technology from Fred Hutchinson Cancer Research Center

Aug 12, 2019

CORRECTING and REPLACING Propanc Biopharma Publishes Key Data in Peer Reviewed Journal Confirming Anti-Cancer Stem Cell Effects of Proenzymes

Jul 1, 2019

Century Therapeutics Launches With USD 250M Financing for Induced Pluripotent Stem Cell (iPSC) Allogeneic Cell Therapy Platform

Jul 1, 2019

Century Therapeutics launches with USD 250M financing for induced pluripotent stem cell (iPSC) allogeneic cell therapy platform

Jun 27, 2019

Global Cancer Stem Cell Therapeutics Market to 2023 - Led by Cellerant Therapeutics, Celularity, Gamida Cell, Nohla Therapeutics, and Sumitomo Dainippon Pharma Co

May 29, 2019

Vor Biopharma Announces Publication of Proof-of-Concept Study of its Lead Program in the Scientific Journal Proceedings of the National Academy of Sciences

May 9, 2019

Promethera Biosciences Announces First-Dosing in Phase 2a Clinical Study Evaluating World’s First Liver Stem Cell Therapy in Late-Stage NASH Patients

Apr 17, 2019

Kiadis to Acquire Cytosen Therapeutics, Inc.

Apr 15, 2019

Promethera Biosciences Presents Updated Phase 2a Results for World’s First Stem Cell Clinical Trial in ACLF at The International Liver Congress™/ EASL 2019

Mar 27, 2019

Promethera Biosciences Announces Late-Breaking Data Presentation at EASL 2019 from World First Liver Stem Cell Clinical Trial in ACLF

Mar 26, 2019

Breath Therapeutics Announces Initiation of Global Phase 3 Trials for the Treatment of Bronchiolitis Obliterans Syndrome

Mar 4, 2019

Celltex Therapeutics Corporation Signs Memorandum of Understanding (MOU) with Saudi Arabia; Expands Presence to Riyadh

Feb 19, 2019

Longeveron Discusses Latest Stem Cell Findings for Aging Frailty at the International Conference on Frailty and Sarcopenia Research

Feb 13, 2019

Poseida Therapeutics Announces Notice of Allowance for New Patents and Registration of New Trademarks

Jan 18, 2019

Longeveron Co-Chairs, Hosts Symposium At The 2019 World Stem Cell Summit And Phacilitate Leaders World Conferences In Miami

Jan 16, 2019

Knopp Biosciences Expands Research Collaboration with Cincinnati Children’s to Characterize Effect of Dexpramipexole in Inflammatory Diseases

Dec 6, 2018

BlueRock Therapeutics Strengthens Collaboration with the McEwen Stem Cell Institute

Nov 28, 2018

Vor Biopharma Announces Issuance of Foundational U.S. Patent Broadly Covering Compositions and Methods to Treat Hematologic Malignancies

Oct 29, 2018

Longeveron Chief Science Officer Dr. Joshua Hare To Address 2018 TEDCO Stem Cell Symposium

Oct 23, 2018

Century Therapeutics Announces Acquisition of Empirica Therapeutics

Oct 23, 2018

Therapeutic Solutions International Selects Premier Regenerative Medicine CRO Biorasi to Initiate and Run Phase III FDA Registration Clinical Trial for JadiCell Universal Donor Adult Stem Cell Product

Oct 18, 2018

Longeveron Receives Prestigious NIH Small Business Innovation Research Grant

Oct 5, 2018

Longeveron Chief Science Officer Dr. Joshua Hare To Keynote 2018 HEALinc Future Health Innovation Summit

Aug 14, 2018

Frequency Therapeutics Strengthens Scientific Advisory Board with Addition of Leading Experts in Neurology, Stem Cell and Regenerative Medicine

Jul 16, 2018

Nohla Therapeutics Receives FDA Orphan Drug Designation for Dilanubicel for Hematopoietic Stem Cell Transplant Patients

Jul 13, 2018

Dr. Joshua Hare To Present Longeveron Regenerative Stem Cell Research At The Sixth Annual Aspen BrainLab

May 26, 2018

Poseida Therapeutics Presents Clinical Manufacturing Method for Durable, Persistent CAR-T Stem Cell Memory Therapies at World Orphan Drug Congress USA

May 23, 2018

Longeveron Recruiting for Stem Cell Alzheimer's Trial in South Florida

May 22, 2018

Longeveron Receives TEDCO Grant To Fund Stem Cell Research

May 2, 2018

Sigilon Therapeutics to Present at the 2nd International Pancreas and Islet Transplant Association-JDRF-Harvard Stem Cell Institute Key Opinion Leaders Meeting on Stem Cell Derived Beta Cells

Apr 11, 2018

AIVITA Biomedical CEO Hans Keirstead to Deliver Plenary Keynote at GTCbio's 15th Stem Cell Summit

Apr 6, 2018

Sigilon Therapeutics to Present at the GTCbio 15th Stem Cell Summit

Feb 27, 2018

First Longeveron Mesenchymal Stem Cell Treatment Administered to an Infant with Rare Heart Condition as Part of Groundbreaking Clinical Trial

Feb 14, 2018

Poseida Therapeutics Presents Stem Cell Memory CAR-T Therapy for Prostate Cancer at 2018 Keystone Symposia on Emerging Cellular Therapies

Jan 23, 2018

Nohla Therapeutics Granted Orphan Drug Designation in the European Union for NLA101 in the Treatment of Hematopoietic Stem Cell Transplantation

Jan 22, 2018

Longeveron to Play Prominent Role at the World Stem Cell Summit in Miami

Jan 4, 2018

SanBio Primary Researcher Receives 2017 Smithsonian American Ingenuity Award

Dec 28, 2017

Stem Cell Leaders Join Frequency Therapeutics’ PCA™ Regenerative Medicine Scientific Advisory Board

Dec 18, 2017

Poseida Therapeutics Announces First Patient Treated in Phase 1 Study of P-BCMA-101 CAR-T Stem Cell Memory Therapy in Patients with Multiple Myeloma

Dec 15, 2017

CIRM Grants ViaCyte $1.4M to Create Immune-Evasive Pluripotent Stem Cell Lines

Oct 17, 2017

Longeveron Pioneering Development of Stem Cell Therapies for Aging Frailty

Oct 5, 2017

Poseida Therapeutics Presents Preclinical Solid Tumor Data for P-PSMA-101, a CAR-T Therapy Predominantly Comprised of Stem Cell Memory T Cells, at the Prostate Cancer Foundation Annual Retreat

Sep 26, 2017

Poseida Therapeutics Opens Enrollment in a Phase 1 Study of BCMA-Specific CAR-T Stem Cell Memory Therapy for Patients with Multiple Myeloma

Sep 6, 2017

Longeveron Initiates Phase 2b Stem Cell Therapy Trial to Treat Aging Frailty

Jun 19, 2017

Frequency Therapeutics Presented Data at the International Society for Stem Cell Research Supporting Progenitor Cell Activation to Restore Healthy Function in Multiple Tissue Types

May 22, 2017

Longeveron to receive Grant from the Maryland Stem Cell Research Fund

May 15, 2017

Longeveron Announces Publication of Phase 1 Safety and Efficacy Trial Results for Allogeneic Stem Cell Treatment in Frailty Patients

May 5, 2017

Frequency Therapeutics to Present at the 14th Stem Cell Research and Regenerative Medicine Conference

Apr 3, 2017

AIVITA Biomedical CEO Hans Keirstead, Ph.D. to Present as Distinguished Speaker at Upcoming Stem Cell Summit 2017

Mar 15, 2017

Longeveron Achieves Milestone in Groundbreaking Stem Cell Trial for Alzheimer's Disease

Dec 14, 2016

VistaGen Therapeutics Grants Exclusive Sublicense of Cardiac Stem Cell Technologies to BlueRock Therapeutics

Dec 12, 2016

Bayer and Versant Ventures Join Forces to Launch Stem Cell Therapy Company BlueRock Therapeutics with USD 225 Million Series A Financing

Nov 29, 2016

Nohla Therapeutics Announces Closing of $43.5M Series A Financing to Transform Stem Cell Transplantation with Innovative Off the Shelf, Universal Donor Cellular Therapy

Nov 4, 2016

SanBio Presents Interim Results of the First Intracerebral Stem Cell Transplant Study for Stroke in the United States

Jun 24, 2016

SanBio Presents Interim Results of Chronic Stroke Phase 1/2a Clinical Trial at International Society of Stem Cell Research Annual Meeting

Jun 22, 2016

Yumanity Therapeutics and the New York Stem Cell Foundation Research Institute Announce Discovery Collaboration

Oct 6, 2014

ViaCyte, Inc. to Present at Upcoming Stem Cell Meeting on the Mesa Conference

Oct 10, 2013

ViaCyte To Present Update On VC-01™ Combination Product Development At 2013 Stem Cell Meeting On The Mesa

Feb 13, 2013

JDRF and California Institute for Regenerative Medicine Increase Funding of ViaCyte

Jan 14, 2013

SanBio Announces Enrollment Of The Second Cohort Of Patients In Its Clinical Trial Of Stem Cell Therapy For Chronic Stroke

May 5, 2010

ViaCyte, Inc., Receives Three Additional U.S. Patents, Supporting its Development of a Stem Cell Derived Treatment for Diabetes

May 5, 2010

Novocell Becomes ViaCyte, Inc., as it Accelerates Pre-Clinical Development of a Stem Cell Derived Treatment for Diabetes